What is the purpose of Oxaltor Oxaliplatin 50mg Injection?
Oxaltor Oxaliplatin 50mg Injection is a drug that is used in combination with other drugs to treat advanced colon or rectal cancer (cancer that begins in the large intestine). Oxaliplatin is also used in combination with other drugs to prevent colon cancer from spreading after surgery to remove the tumor.
What cancers are Oxaltor Oxaliplatin 50mg Injection used to treat?
Oxaltor Oxaliplatin 50mg Injection is a chemotherapeutic medication. Eloxatin is another name for it. It’s a cancer treatment for colon cancer and other cancers. Oxaliplatin is frequently used with other chemotherapeutic drugs.
What are the oxaliplatin side effects?
- Allergic Reactions as a Side Effect of Oxaliplatin Patients may experience an adverse reaction to this drug in some situations.
- Low Red Blood Cell Count (Anemia).
- Fatigue. Liver Toxicity. Diarrhea. Constipation.
- Peripheral Neuropathy (Numbness or Tingling in the Hands and/or Feet)
Is Oxaliplatin causing you to lose your hair?
Some or all of your hair may fall out around 3 to 4 weeks after treatment begins. Hair on your head, as well as facial and body hair, may fall out. Before your hair starts to fall out, you might want to invest in a wig. During treatment, hair may regrow.
Is it possible to drink when taking Oxaliplatin?
Avoid chilly temperatures and cold objects when having Oxaliplatin treatment. If you must go outside in chilly weather, cover your skin, mouth, and nose. Drinking cold drinks or using ice cubes in drinks is not recommended.
Is it possible that oxaliplatin will harm your liver?
The chemotherapy medication oxaliplatin is routinely used to treat advanced colorectal cancer (CRC). However, the therapy may cause liver damage. Sinusoidal obstruction syndrome is a dangerous kind of liver injury that can occur as a result of oxaliplatin treatment (SOS).
Who is the manufacturer of oxaliplatin?
The Sanofi-aventis Group announced today that a novel aqueous solution formulation of ELOXATINTM has been approved for commercialization by the US Food and Drug Administration (oxaliplatin injection).